| 标题 |
Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristics |
| 网址 | |
| DOI | |
| 其它 |
期刊:American Heart Journal 作者:Cian P. McCarthy; Christie M. Ballantyne; Ron Blankstein; Matthew J. Budoff; Marc Ditmarsch; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)